La Jolla, CA, United States of America

Sukumar Sakamuri

This inventor holds 1 USPTO granted patent. Top assignee: Ambrx, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sukumar Sakamuri. Retrieved from https://idiyas.com/inventor/sukumar-sakamuri-1wy94guw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sukumar Sakamuri: Innovator in Antibody-TLR Agonist Conjugates

Introduction

Sukumar Sakamuri is a notable inventor based in La Jolla, California. He has made significant contributions to the field of biotechnology, particularly in the development of antibody-TLR agonist conjugates. His innovative work has the potential to impact therapeutic strategies in various medical applications.

Latest Patents

Sakamuri holds a patent for "Compositions Containing, Methods and Uses of Antibody-TLR Agonist Conjugates." This patent highlights his expertise in creating novel compositions that combine antibodies with TLR agonists, which can enhance immune responses.

Career Highlights

Sukumar Sakamuri is currently employed at Ambrx, Inc., a company known for its advancements in protein therapeutics. His role at Ambrx allows him to further explore and develop his innovative ideas in the biotechnology sector.

Collaborations

Sakamuri has collaborated with talented individuals such as Sung-Ju Moon and Brian Leon. These partnerships have fostered a creative environment that encourages the exchange of ideas and enhances the development of groundbreaking technologies.

Conclusion

Sukumar Sakamuri is a distinguished inventor whose work in antibody-TLR agonist conjugates exemplifies the innovative spirit of modern biotechnology. His contributions continue to pave the way for advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…